Endemic – PharmaLive

The Prescriber in 2022: Engaging HCPs in the COVID-Endemic Era

Brands, Consumers, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Drug Delivery, Endemic, Europe, HCPs, Medical Devices, Mobile, Pharma, Physicians, Prescribers, Reports, Research, Telehealth, United States

Of all the communities touched by the COVID-19 pandemic, healthcare professionals (HCPs) are arguably among those most affected. Specialists on the front lines in primary care, critical care, infectious diseases, and pulmonology roles have experienced COVID-19 first hand—often risking their own health and that of their families to help. A new report from Apollo Intelligence provides a barometer on physicians’ sentiments for 2022, and together with other research, frames a wake-up call to medical device and pharma teams in charge of building a brand presence with prescribers.

April 26, 2022/by Andrew Humphreys

Moderna Announces Triple Threat Booster Against Viruses

Business, CDC, Clinical Trials, COVID-19 Vaccinations, Endemic, Hospitalized COVID-19 Patients, Immunogenicity, Influenza, Messenger RNA (mRNA) Vaccines, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), R&D, Respiratory Syncytial Virus (RSV) Infection, SARS-CoV-2 virus, Vaccines, Viruses

Moderna is broadening the company’s vaccine horizons once again using mRNA technology, widely known for its use in COVID-19 vaccinations. Moderna announced two new vaccine development programs targeting a variety of viruses.

March 22, 2022/by BioSpace

U.S. CDC stands by K-12 school masking guidance as states relax rules – Walensky

CDC, CDC Director Rochelle Walensky, Children, Coronavirus Cases, COVID-19 Crisis, COVID-19 protocols, Data, Endemic, High School, Hospitalized COVID-19 Patients, Mask-wearing, Schools

With COVID-19 cases still high nationwide, “now is not the moment” to drop mask mandates in schools and other public places, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky told Reuters on February 8.

February 8, 2022/by Reuters Health

J&J Suffers New Warning Label, Woodcock: “Most People are Going to Get COVID”

Adverse Events, Bleeding Disorders, Cannabinoids, Chronic Immune Thrombocytopenia (ITP), Coronavirus Disease (COVID-19) Pandemic, COVID-19 Infections, Dr. Anthony Fauci (Director), Endemic, FDA, FDA Commissioner, Immunogenicity Data, Janssen, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, National Institute of Allergy and Infectious Diseases (NIAID), Novavax, Omicron (B.1.1.529) (South Africa), South Korea

The U.S. Food and Drug Administration added another warning to the regulatory agency’s fact sheet for Johnson & Johnson’s COVID-19 vaccine. In other news, as the Omicron variant rips through the United States, top health officials have noted that the variant is so contagious that if you come into contact with it, you are likely to catch it.

January 12, 2022/by BioSpace

FDA Gives Nod to Pfizer’s Tick-Borne Encephalitis Vaccine

Approvals, CDC, COVID-19 booster shots, Endemic, European Center for Disease Prevention and Control (ECDC), FDA, Pfizer, Tick-Borne Diseases, Tick-Borne Encephalitis (TBE)

The U.S. Food and Drug Administration approved Pfizer’s tick-borne encephalitis vaccine TICOVAC to prevent TBE in people aged 1 year and older.

August 16, 2021/by Andrew Humphreys

Can COVID-19 be Eradicated? New Zealand Researchers Say “Yes”

BMJ Global Health, Coronavirus, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccinations, Endemic, Medical Journals, Nature, New Zealand, Outbreaks, Polio, Public Health, Researchers, Smallpox

Covid-19 probably can be eradicated globally, just like polio, according to research just published in BMJ Global Health. That assumes, however, that a high rate of vaccination occurs globally and that there is a quick response to emerging variants.

August 12, 2021/by Andrew Humphreys

U.S. FDA Approves Lampit for Chagas Disease in Children

Antibody Tests, Approvals, Chagas Disease, Children, Endemic, FDA, FDA/Regulatory, Latin America, Pediatric Patients, Tropical Diseases, United States

The United States Food and Drug Administration approved Bayer’s Lampit (nifurtimox) for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.

August 7, 2020/by Andrew Humphreys

Sanofi wins U.S. approval to sell dengue vaccine but with major restrictions

Approvals, Endemic, European Medicines Agency (EMA), FDA, FDA/Regulatory, Philippines, Puerto Rico, Vaccinations, Vaccines, World Health Organization

The U.S. FDA gave Sanofi SA’s dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine can cause severe infections in some people.

May 1, 2019/by Reuters Health

Novartis to Spend $100M on Malaria Initiative

Biotech, Endemic, Initiatives, Malaria, World Health Organization

Novartis announced a five-year commitment in the fight against malaria. The Swiss-based company will invest more than $100 million to advance research and the development of “next-generation treatments” to combat emerging resistance to artemisinin and other currently used antimalarials.

April 17, 2018/by BioSpace

Sanofi says new data analyses support its dengue vaccine

Dengue, Endemic, Health, Studies, Vaccines

French drugmaker Sanofi said on Monday that new data analyses published in the New England Journal of Medicine confirmed that its vaccine candidate against dengue protected two-thirds of the participants […]

July 27, 2015/by Reuters Health